Literature DB >> 15457154

A prospective, single-center clinical trial of a modified Cox maze procedure with bipolar radiofrequency ablation.

Sydney L Gaynor1, Michael D Diodato, Sunil M Prasad, Yosuke Ishii, Richard B Schuessler, Marci S Bailey, Nicholas R Damiano, Jeffrey B Bloch, Marc R Moon, Ralph J Damiano.   

Abstract

OBJECTIVE: The Cox maze III procedure has excellent long-term efficacy in curing atrial fibrillation. It has not been widely practiced because it is technically challenging and requires prolonged cardiopulmonary bypass. The aim of this study was to examine a simplified Cox maze III procedure that uses bipolar radiofrequency energy as an ablative source.
METHODS: Beginning January 2002, a total of 40 consecutive patients underwent a modified Cox maze III procedure with bipolar radiofrequency energy. Nineteen had a lone maze procedure and 21 had a maze procedure plus a concomitant operation. One month after the operation, the first 8 patients were investigated with high-resolution magnetic resonance imaging. Patients were followed up monthly with clinical examination and electrocardiography.
RESULTS: There was no operative deaths. The crossclamp times were 47 +/- 26 minutes for the modified lone Cox maze III procedure and 92 +/- 37 minutes for the Cox maze III procedure plus concomitant procedures. These were significantly shorter than our previous times for the traditional Cox maze III procedure (93 +/- 34 minutes and 122 +/- 37 minutes, respectively, P <.05). Follow-up magnetic resonance imaging showed no evidence of pulmonary vein stenosis, and atrial contractility was preserved in all patients. There were no late strokes. At 6-month follow-up, 91% of patients (21/23) were in sinus rhythm.
CONCLUSIONS: Bipolar radiofrequency ablation can be used to replace the surgical incisions of the Cox maze procedure. This energy source did not result in pulmonary vein stenosis. The modification of the Cox maze III procedure to use bipolar radiofrequency ablation simplified and shortened this procedure without sacrificing short-term efficacy.

Entities:  

Mesh:

Year:  2004        PMID: 15457154     DOI: 10.1016/j.jtcvs.2004.02.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  83 in total

1.  Cox-Maze IV results for patients with lone atrial fibrillation versus concomitant mitral disease.

Authors:  Lindsey L Saint; Marci S Bailey; Sunil Prasad; Tracey J Guthrie; Jennifer Bell; Marc R Moon; Jennifer S Lawton; Nabil A Munfakh; Richard B Schuessler; Ralph J Damiano; Hersh S Maniar
Journal:  Ann Thorac Surg       Date:  2012-02-02       Impact factor: 4.330

2.  Chronic performance of a novel radiofrequency ablation device on the beating heart: Limitations of conduction delay to assess transmurality.

Authors:  Anson M Lee; Abdulhameed Aziz; Kal L Clark; Richard B Schuessler; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2012-02-02       Impact factor: 5.209

Review 3.  Ablation technology for the surgical treatment of atrial fibrillation.

Authors:  Spencer J Melby; Richard B Schuessler; Ralph J Damiano
Journal:  ASAIO J       Date:  2013 Sep-Oct       Impact factor: 2.872

4.  Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery.

Authors:  Lindsey L Saint; Ralph J Damiano; Phillip S Cuculich; Tracey J Guthrie; Marc R Moon; Nabil A Munfakh; Hersh S Maniar
Journal:  J Thorac Cardiovasc Surg       Date:  2013-08-30       Impact factor: 5.209

5.  Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease.

Authors:  William Clifford Roberts; Hassan Farooq
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

6.  Biatrial lesion sets.

Authors:  Ralph J Damiano; Rochus K Voeller
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

7.  Pulmonary vein isolation and the Cox maze procedure only partially denervate the atrium.

Authors:  Shelly C Lall; Kelley V Foyil; Shun-ichiro Sakamoto; Rochus K Voeller; John P Boineau; Ralph J Damiano; Richard B Schuessler
Journal:  J Thorac Cardiovasc Surg       Date:  2008-03-04       Impact factor: 5.209

8.  Right atrial lesions do not improve the efficacy of a complete left atrial lesion set in the surgical treatment of atrial fibrillation, but they do increase procedural morbidity.

Authors:  Lori K Soni; Sophia R Cedola; Jacob Cogan; Jeffrey Jiang; Jonathan Yang; Hiroo Takayama; Michael Argenziano
Journal:  J Thorac Cardiovasc Surg       Date:  2013-02       Impact factor: 5.209

9.  NORMAL QUALITY OF LIFE AFTER THE COX MAZE PROCEDURE FOR ATRIAL FIBRILLATION.

Authors:  Spencer J Melby; Andreas Zierer; Jordon G Lubahn; Marci S Bailey; James L Cox; Richard B Schuessler; Ralph J Damiano
Journal:  Innovations (Phila)       Date:  2008-05-01

Review 10.  Curing atrial fibrillation: Two decades of progress.

Authors:  N A Mark Estes; Ralph J Damiano
Journal:  J Interv Card Electrophysiol       Date:  2007-12       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.